SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 323 filers reported holding SEATTLE GENETICS INC in Q3 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $178,869,000 | +4.3% | 914,044 | -9.4% | 2.41% | -3.9% |
| Q2 2020 | $171,520,000 | +46.0% | 1,009,417 | -0.9% | 2.50% | +26.6% |
| Q1 2020 | $117,506,000 | -7.6% | 1,018,426 | -8.5% | 1.98% | +20.0% |
| Q4 2019 | $127,217,000 | +30.7% | 1,113,399 | -2.3% | 1.65% | +22.1% |
| Q3 2019 | $97,331,000 | +18.8% | 1,139,709 | -3.9% | 1.35% | +33.8% |
| Q2 2019 | $81,899,000 | -4.6% | 1,185,735 | +1.0% | 1.01% | -7.1% |
| Q1 2019 | $85,871,000 | +35.5% | 1,174,026 | +5.0% | 1.09% | +17.7% |
| Q4 2018 | $63,381,000 | -21.2% | 1,118,626 | +7.3% | 0.92% | -7.9% |
| Q3 2018 | $80,436,000 | +13.7% | 1,042,995 | -2.1% | 1.00% | +8.4% |
| Q2 2018 | $70,738,000 | +29.7% | 1,065,495 | +2.2% | 0.92% | +24.7% |
| Q1 2018 | $54,557,000 | +28.4% | 1,042,352 | +31.2% | 0.74% | +27.5% |
| Q4 2017 | $42,497,000 | -6.4% | 794,336 | -4.8% | 0.58% | +0.3% |
| Q3 2017 | $45,406,000 | +51.1% | 834,519 | +43.7% | 0.58% | +47.0% |
| Q2 2017 | $30,049,000 | – | 580,766 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,365,840,000 | 20.68% |
| Lagoda Investment Management, L.P. | 398,529 | $20,620,000 | 7.88% |
| Matrix Capital Management Company, LP | 2,118,000 | $109,585,000 | 3.72% |
| Ghost Tree Capital, LLC | 300,000 | $15,522,000 | 3.23% |
| Sio Capital Management, LLC | 100,000 | $5,174,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 249,500 | $12,909,000 | 2.31% |
| Redmile Group, LLC | 665,139 | $34,414,000 | 2.10% |
| Eventide Asset Management | 525,000 | $27,164,000 | 1.69% |
| Opus Point Partners Management, LLC | 35,093 | $1,816,000 | 1.66% |
| Boxer Capital, LLC | 125,000 | $6,468,000 | 1.54% |